Efficacy of cyclosporin a in rheumatoid arthritis: worldwide experience
Dougados, M.; Torley, H.
British Journal of Rheumatology 32(Suppl 1): 57-59
1993
ISSN/ISBN: 0263-7103 PMID: 8448640 Document Number: 410395
The effects of cyclosporin A (CyA) on the activity of RA have mainly been investigated in patients with active, refractory, long-term disease. The data obtained in these trials suggest that CyA is not only a symptomatic treatment for RA but can also be considered a DMARD. The potential benefits of CyA on one hand and its potential toxicity on the other indicate that a careful assessment should be made of its use in patients with early active RA.
Document emailed within 1 workday
Related Documents
Codullo, V.; Iannone, F.; Sinigaglia, L.; Favalli, E.G.; Sarzi-Puttini, P.; Atzeni, F.; Ferraccioli, G.; Gremese, E.; Carletto, A.; Giollo, A.; Govoni, M.; Bergossi, F.; Galeazzi, M.; Cantarini, L.; Salaffi, F.; Di Carlo, M.; Bazzani, C.; Pellerito, R.; Sebastiani, M.; Ramonda, R.; Lapadula, G.; Caporali, R. 2017: Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries Clinical and Experimental Rheumatology 35(4): 660-665Tumiati, B.; Bellelli, A.; Baricchi, R.; Portioli, R.I. 1985: Cyclosporin for rheumatoid arthritis: one case Clinical and Experimental Rheumatology 3(4): 361-362
Medvedev, A.N.; Korshunov, N.I.; Nasonov, E.L.; Baranov, A.A.; Shilkina, B.N. 1997: The effect of cyclosporin a (Sandimmun) on the level of soluble interleukin-2 receptors in rheumatoid arthritis Terapevticheskii Arkhiv 69(8): 19-21
Marbet, U.A.; Graf, U.; Mihatsch, M.J.; Gratwohl, A.; Müller, W.; Thiel, G. 1980: Renal side effects of treatment with cyclosporin A in rheumatoid arthritis and after bone marrow transplantation Schweizerische Medizinische Wochenschrift 110(52): 2017-2020
Sund, S.; Førre, O.; Berg, K.J.; Kvien, T.K.; Hovig, T. 1994: Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis Clinical Nephrology 41(1): 33-40
Ferraccioli, G.; Casatta, L.; Bartoli, E. 1996: Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy Journal of Rheumatology 23(9): 1539-1542
Warabi, H.; Ogawa, N.; Azuma, T. 1989: Assessment of efficacy of RPY-001 in rheumatoid arthritis Ryumachi 29(4): 303-317
Islam, M.N.; Alam, M.N.; Haq, S.A.; Moyenuzzaman, M.; Patwary, M.I.; Rahman, M.H. 2000: Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis Bangladesh Medical Research Council Bulletin 26(1): 1-7
Ilić, T.; Milić, B.; Ćelić, D.; Vučković, B.; Mitić, I. 2013: Etanercept therapy in rheumatoid arthritis: efficacy and safety Srpski Arhiv Za Celokupno Lekarstvo 141(7-8): 495-502
Frizen, B.N.; Dormidontov, E.N. 1992: The efficacy of basic therapy in rheumatoid arthritis with methotrexate Terapevticheskii Arkhiv 64(5): 34-36
Antoniuk, M.V.; Magalish, T.L. 2005: Efficacy of sodium gumate electrophoresis in rheumatoid arthritis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 20-22
Morović-Vergles, J. 2003: Rofecoxib: its efficacy in rheumatoid arthritis and acute pain Reumatizam 50(2): 47-48
Lemmel, E.M.; Bolten, W.; Burgos-Vargas, R.; Platt, P.; Nissilä, M.; Sahlberg, D.; Björneboe, O.; Baumgartner, H.; Valat, J.P.; Franchimont, P.; Bluhmki, E.; Hanft, G.; Distel, M. 1997: Efficacy and safety of meloxicam in patients with rheumatoid arthritis Journal of Rheumatology 24(2): 282-290
Madhok, R.; Torley, H.I.; Capell, H.A. 1991: A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis Journal of Rheumatology 18(10): 1485-1489
Bathon, J.M.; Fleischmann, R.M.; Van der Heijde, Désirée.; Tesser, J.R.; Peloso, P.M.; Chon, Y.; White, B. 2006: Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis Journal of Rheumatology 33(2): 234-243
Kurowski, M.; Menninger, H.; Pauli, E. 1994: The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients International Journal of Clinical Pharmacology and Therapeutics 32(8): 433-440
Li, Q.-C.; Han, X.-H.; Zhou, B.; Wang, W.-F.; Ren, G.-P.; Sun, C.-Y.; Wu, Q.; Yu, Y.-H.; Xu, L.-M.; Wang, Q.-Y.; Qi, J.-Y.; Wei, Y.-Q.; Cao, H.-W.; Han, J.-Y.; Li, D.-S. 2014: Therapeutic efficacy of three bispecific antibodies on rheumatoid arthritis mice models Yao Xue Xue Bao 49(3): 322-328
Fleischmann, R. 2002: In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritis Journal of rheumatology 29(9): 2018-9; author reply 2019
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683